Skip to main content
Market intelligence
NBPSector not reported

NovaBridge Biosciences insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jul 6, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 6, 2026Cong Claire XuSVP, Clinical DevelopmentSale4,485$0.89$3,992
Jun 18, 2026Phillip Andrew DennisChief Medical OfficerSale8,494$0.66$5,606
Jun 1, 2026Cong Claire XuSVP, Clinical DevelopmentSale3,494$3.94$13,766